Maltodextrin

Generic Name: Maltodextrin

Drug Type: Small Molecule

CAS Number: 9050-36-6

Unique Ingredient Identifier: 7CVR7L4A2D

Clinical Trials

Psilocybin with Psychological Support (Psi-PS) for Military Veterans and First Responders with Co-occurring PTSD & Alcohol Use Disorder (AUD)

Phase 2

Not yet recruiting

Conditions: Alcohol Use Disorder (AUD)
PTSD

Interventions: Drug: Psilocybin 25 mg
Drug: Maltodextrin (Placebo)

First Posted Date: 2025-03-03

Last Posted Date: 2025-03-03

Lead Sponsor: Nathan Brashares Sackett

Target Recruit Count: 40

Registration Number: NCT06853912

Locations: 🇺🇸
University of Washington Center for Novel Therapeutics in Addiction Psychiatry, Seattle, Washington, United States

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Phase 3

Recruiting

Conditions: Mobility
Joint Pain
Chronic Inflammation
Muscle Pain

Interventions: Drug: Maolactin
Drug: Maltodextrin

First Posted Date: 2024-06-06

Last Posted Date: 2025-03-10

Lead Sponsor: RDC Clinical Pty Ltd

Target Recruit Count: 100

Registration Number: NCT06444763

Locations: 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

Phase 3

Recruiting

Conditions: Circulatory; Change

Interventions: Drug: Maltodextrin
Drug: Grape Seed Extract

First Posted Date: 2024-06-03

Last Posted Date: 2024-12-05

Lead Sponsor: RDC Clinical Pty Ltd

Target Recruit Count: 150

Registration Number: NCT06440252

Locations: 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population

Phase 3

Recruiting

Conditions: Muscle Fatigue
Post Exercise Inflammation
Exercise Recovery
Muscle Pain

Interventions: Drug: Maolactin
Drug: Maltodextrin

First Posted Date: 2024-05-31

Last Posted Date: 2024-10-16

Lead Sponsor: RDC Clinical Pty Ltd

Target Recruit Count: 40

Registration Number: NCT06436781

Locations: 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia

Effect of Maolactin on Gastrointestinal Tract (GIT) Health

Phase 3

Recruiting

Conditions: Gastrointestinal Dysfunction

Interventions: Drug: High Dose Maolactin
Drug: Low Dose Maolactin
Drug: Maltodextrin

First Posted Date: 2023-10-27

Last Posted Date: 2025-04-02

Lead Sponsor: RDC Clinical Pty Ltd

Target Recruit Count: 90

Registration Number: NCT06104917

Locations: 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia

Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

Phase 2

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Drug: Psilocybin
Drug: Maltodextrin

First Posted Date: 2022-06-13

Last Posted Date: 2023-08-24

Lead Sponsor: Anders Fink-Jensen, MD, DMSci

Target Recruit Count: 90

Registration Number: NCT05416229

Locations: 🇩🇰
Psychiatric Center Copenhagen, Frederiksberg Hospital, Frederiksberg, Denmark

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Phase 4

Not yet recruiting

Conditions: Left Ventricular Dysfunction
Quality of Recovery
Right Ventricular Dysfunction

Interventions: Drug: Maltodextrin solution
Drug: Placebo solution

First Posted Date: 2022-01-12

Last Posted Date: 2025-02-24

Lead Sponsor: Jewish General Hospital

Target Recruit Count: 70

Registration Number: NCT05188222

Locations: 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada

Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males

Phase 2

Conditions: Sarcopenia

Interventions: Drug: Creatine monohydrate
Drug: Maltodextrin Powder

First Posted Date: 2018-05-21

Last Posted Date: 2018-05-21

Lead Sponsor: University of Regina

Target Recruit Count: 40

Registration Number: NCT03530202

Locations: 🇨🇦
University of Regina, Regina, Saskatchewan, Canada

Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition

Phase 2

Withdrawn

Conditions: Anxiety
Pain
Surgery

Interventions: Drug: Galacto-Oligosaccharide
Drug: Maltodextrin (Placebo)

First Posted Date: 2016-11-03

Last Posted Date: 2018-01-31

Lead Sponsor: Jeff Taekman, M.D.

Registration Number: NCT02953691

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Effect of a Synbiotic on Symptoms of Patients With STC

Phase 2

Completed

Conditions: Slow Transit Constipation

Interventions: Drug: bifid triple viable capsule and pectin
Drug: maltodextrin

First Posted Date: 2016-07-26

Last Posted Date: 2016-09-30

Lead Sponsor: Jinling Hospital, China

Target Recruit Count: 100

Registration Number: NCT02844426

Locations: 🇨🇳
Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University, Nanjing, Jiangsu, China

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy